Prospective validation of a risk score based on biological markers for predicting progression free survival in Binet stage A chronic lymphocytic leukemia patients: Results of the multicenter O-CLL1-GISL study

American Journal of Hematology

Volumn 89, Issue 7, 2014, Pages 743-750

  Gentile, Massimo ^a   Cutrona, Giovanna ^b   Mosca, Laura ^c   Matis, Serena ^b   Fabris, Sonia ^c   Lionetti, Marta ^c   Ilariucci, Fiorella ^d   Zupo, Simona ^b   Musolino, Caterina ^e   Levato, Luciano ^f   Molica, Stefano ^f   Di Raimondo, Francesco ^g   Vincelli, Iolanda ^a   Di Rienzo, Nicola ^h   Pesce, Emanuela Anna ⁱ   Angrilli, Francesco ^j   Federico, Massimo ^k   Neri, Antonino ^c   Ferrarini, Manlio ^b   Morabito, Fortunato ^a  

^a Hematology Unit   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

^d Division of Haematology   (Italy)

^e UNIVERSITY OF MESSINA   (Italy)

^f PUGLIESE CIACCIO HOSPITAL   (Italy)

^g UNIVERSITY OF CATANIA   (Italy)

^h VITO FAZZI HOSPITAL   (Italy)

ⁱ GISL Trial Office   (Italy)

^j SPIRITO SANTO HOSPITAL   (Italy)

^k UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 MICROGLOBULIN; BIOLOGICAL MARKER; CD38 ANTIGEN; IMMUNOGLOBULIN HEAVY CHAIN; NOTCH1 RECEPTOR; PROTEIN KINASE ZAP 70;

ADULT; ARTICLE; CANCER PROGNOSIS; CANCER STAGING; CHRONIC LYMPHATIC LEUKEMIA; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; FOLLOW UP; GENE EXPRESSION; GENE EXPRESSION PROFILING; HIGH RISK PATIENT; HIGH RISK POPULATION; HUMAN; LEUKEMIA CELL; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MONOCLONAL B CELL LYMPHOCYTOSIS; MULTICENTER STUDY; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; PROGRESSION RISK SCORE; PROSPECTIVE STUDY; SCORING SYSTEM;

BIOLOGICAL MARKERS; CHRONIC LYMPHOCYTIC LEUKEMIA; EARLY STAGE; GENE EXPRESSION PROFILES; PROGNOSIS;

COHORT STUDIES; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; FEMALE; GENE EXPRESSION PROFILING; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; TUMOR MARKERS, BIOLOGICAL;

EID: 84902791001     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.23729     Document Type: Article

References (32)

1. Rozman C, Montserrat E. Chronic lymphocytic leukemia. N Engl J Med 1995;333:1052-1057.
2. Rai KR, Sawitsky A, Cronkite EP, et al. Clinical staging of chronic lymphocytic leukemia. Blood 1975;46:219-234.
3. Binet JL, Auquier A, Dighiero G, et al. A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis. Cancer 1981;48:198-206.
4. Call T, Phyilky R, Noel P, et al. Incidence of chronic lymphocytic leukemia in Olmsted County, Minnesota, 1935 through 1989, with emphasis on changes in initial stage at diagnosis. Mayo Clin Proc 1994;69:323-328.
5. Molica S, Levato D, Dattilo A. Natural history of early chronic lymphocytic leukemia. A single institution study with emphasis on the impact of disease-progression on overall survival. Haematologica 1999;84:1094-1099.
6. Rozman C, Bosch F, Montserrat E. Chronic lymphocytic leukemia: A changing natural history? Leukemia 1997;11:775-778.
7. Dohner H, Stilgenbauer S, Benner A, et al. Genomic aberrations and survival in chronic lymphocytic leukemia. N Engl J Med 2000;343:1910-1916.
8. Hamblin TJ, Davis Z, Gardiner A, et al. Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood 1999;94:1848-1854.
9. Damle RN, Wasil T, Fais F, et al. Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood 1999;94:1840-1847.
10. Morabito F, Cutrona G, Gentile M, et al. Definition of progression risk based on combinations of cellular and molecular markers in patients with Binet stage A chronic lymphocytic leukaemia. Br J Haematol 2009;146:44-53.
11. Shanafelt TD, Geyer SM, Bone ND, et al. CD49d expression is an independent predictor of overall survival in patients with chronic lymphocytic leukaemia: A prognostic parameter with therapeutic potential. Br J Haematol 2008;140:537-546.
12. Gentile M, Cutrona G, Neri A, et al. Predictive value of beta2-microglobulin (beta2-m) levels in chronic lymphocytic leukemia since Binet A stages. Haematologica 2009;94:887-888.
13. Morabito F, De Filippi R, Laurenti L, et al. The cumulative amount of serum-free light chain is a strong prognosticator in chronic lymphocytic leukemia. Blood 2011;118:6353-6361.
14. Gentile M, Cutrona G, Fabris S, et al. Total body computed tomography scan in the initial work-up of Binet stage A chronic lymphocytic leukemia patients: Results of the prospective, multicenter O-CLL1-GISL study. Am J Hematol 2013 88;539-544.
15. Cheson BD, Bennett JM, Grever M, et al. National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: Revised guidelines for diagnosis and treatment. Blood 1996;87:4990-4997.
16. Hallek M, Cheson BD, Catovsky D, et al. Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines. Blood 2008;111:5446-5456.
17. Cutrona G, Colombo M, Matis S, et al. Clonal heterogeneity in chronic lymphocytic leukemia cells: Superior response to surface IgM cross-linking in CD38, ZAP-70-positive cells. Haematologica 2008;93:413-422.
18. Lionetti M, Fabris S, Cutrona G, et al. High-throughput sequencing for the identification of NOTCH1 mutations in early stage chronic lymphocytic leukemia: biological and clinical implications. Br J Haematol 2014 Mar 2; [Epub ahead of print].
19. Irizarry RA, Hobbs B, Collin F, et al. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 2003;4:249-264.
20. Dai M, Wang P, Boyd AD, et al. Evolving gene/transcript definitions significantly alter the interpretation of GeneChip data. Nucleic Acids Res 2005;33:e175.
21. Ronchetti D, Tuana G, Rinaldi A, et al. Distinct patterns of global promoter methylation in early stage chronic lymphocytic leukemia. Genes Chromosomes Cancer 2014;53:264-273.
22. Rossi D, Rasi S, Spina V, et al. Integrated mutational and cytogenetic analysis identifies new prognostic subgroups in chronic lymphocytic leukemia. Blood 2013;121:1403-1412.
23. Wierda WG, O'Brien S, Wang X, et al Prognostic nomogram and index for overall survival in previously untreated patients with chronic lymphocytic leukemia. Blood 2007;109:4679-4685.
24. Chiorazzi N. Implications of new prognostic markers in chronic lymphocytic leukemia. Hematol Am Soc Hematol Educ Program 2012;2012:76-87.
25. Shanafelt TD, Rabe KG, Kay NE, et al. Age at diagnosis and the utility of prognostic testing in patients with chronic lymphocytic leukemia. Cancer 2010;116:4777-4787.
26. Wiestner A. Emerging role of kinase targeted strategies in chronic lymphocytic leukemia. Hematol Am Soc Hematol Educ Program 2012;2012:88-96.
27. Eisele L, Prinz R, Klein-Hitpass L, et al. Combined PER2 and CRY1 expression predicts outcome in chronic lymphocytic leukemia. Eur J Haematol 2009;83:320-327.
28. Hanoun M, Eisele L, Suzuki M, et al. Epigenetic silencing of the circadian clock gene CRY1 is associated with an indolent clinical course in chronic lymphocytic leukemia. PLoS One 2012;7:e34347.
29. Mansouri M, Sevov M, Fahlgren E, et al. Lipoprotein lipase is differentially expressed in prognostic subsets of chronic lymphocytic leukemia but displays invariably low catalytical activity. Leuk Res 2010;34:301-306.
30. Ronchetti D, Mosca L, Cutrona G, et al. Small nucleolar RNAs as new biomarkers in chronic lymphocytic leukemia. BMC Med Genomics 2013;6:27.
31. Mansouri L, Gunnarsson R, Sutton LA, et al. Next generation RNA-sequencing in prognostic subsets of chronic lymphocytic leukemia. Am J Hematol 2012;87:737-740.
32. Duzkale H, Schweighofer CD, Coombes KR, et al. LDOC1 mRNA is differentially expressed in chronic lymphocytic leukemia and predicts overall survival in untreated patients. Blood 2011;117:4076-4084.